Teijin Limited - Introduction

Introduction

1-6-7 Minami Honmachi
Chuo-ku
Osaka 541-8587
Japan
Telephone: (06) 6268-2132
Fax: (06) 6268-3205
Web site: http://www.teijin.co.jp

Public Company
Incorporated: 1918 as Teikoku Jinzo Kenshi Co., Ltd.
Employees: 23,265
Sales: ¥890.43 billion ($7.41 billion) (2003)
Stock Exchanges: Tokyo Osaka Nagoya Fukuoka Sapporo
Ticker Symbol: 3401
NAIC: 325211 Plastics Material and Resin Manufacturing; 325222 Noncellulosic Organic Fiber Manufacturing; 325411 Medicinal and Botanical Manufacturing; 325412 Pharmaceutical Preparation Manufacturing; 333292 Textile Machinery Manufacturing; 339113 Surgical and Medical Instrument Manufacturing

Teijin Limited is one of the leading Japanese manufacturers of synthetic fibers, with fibers and textiles accounting for 55 percent of the company's total sales in fiscal 2003. Approximately 20 percent of revenues are derived from Teijin's films and plastics units, which produce such products as polyester film, polyethylene naphthalate (PEN) film and resin, and polyethylene terephthalate (PET) resin. The company's pharmaceuticals and home healthcare unit, though relatively small and limited largely to the Japanese market, is Teijin's biggest generator of earnings, accounting for more than 45 percent of 2003 operating income; about 10 percent of sales originate with this unit, which concentrates on three main therapeutic areas: respiratory, cardiovascular, and osteoporosis. More than 70 percent of Teijin's revenues are generated domestically. Sales outside Japan are made principally in Thailand, Indonesia, China, the United States, Mexico, Italy, and the Netherlands.